FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
#1 | |||
|
||||
Senior Member
|
A new protein capable of reducing the risk of Parkinson's disease identified | TheHealthSite.com
LAG3 inhibitor made by Norvartis is in Phase 1/2 clinical trial for solid tumor cancers. Beyond PD-1[mdash]selected immuno-oncology drug therapies in development : Immuno-oncology moves beyond PD-1 : Nature Biotechnology : Nature Research
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
![]() |
![]() |
|
|